Jaguar Health, Inc. has announced that it will implement a 1-for-15 reverse stock split of its issued and outstanding common stock. The transaction is set to become effective at 12:01 a.m. Eastern Time on September 17, 2026. This action was authorized by the company’s board of directors following approval from stockholders at a special meeting held on April 20, 2026.
The reverse stock split will automatically reclassify every 15 shares of common stock held immediately prior to the effective date into one share of common stock. The par value per share will remain unchanged. As a result of the split, the total number of authorized shares of common stock and preferred stock has not been altered.
Consequently, the number of shares issuable upon the exercise or vesting of outstanding stock options and warrants will be reduced proportionally. The conversion and exercise prices for these instruments will increase proportionately to reflect the split. Additionally, the number of shares reserved for issuance under the company’s equity compensation plans will be reduced accordingly.
No fractional shares will be issued as a result of the split. Stockholders who would otherwise be entitled to a fractional share will receive a cash payment in lieu of that share. Equiniti Trust Company, LLC is serving as the exchange agent for the transaction. The company’s common stock will continue to trade on The Nasdaq Capital Market under the symbol "JAGX" beginning on September 17, 2026, on a split-adjusted basis. The new CUSIP number for the stock following the split is 47010C854.
